Edition:
United States

BioTelemetry Inc (BEAT.OQ)

BEAT.OQ on NASDAQ Stock Exchange Global Select Market

29.95USD
4:00pm EDT
Change (% chg)

$-0.80 (-2.60%)
Prev Close
$30.75
Open
$30.50
Day's High
$31.20
Day's Low
$29.45
Volume
237,635
Avg. Vol
116,134
52-wk High
$39.20
52-wk Low
$15.30

Chart for

About

BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized laboratory services for clinical research. The Company operates in three segments: Healthcare, Technology and Research. The Healthcare segment, operating as CardioNet, LLC... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $995.07
Shares Outstanding(Mil.): 32.36
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 29.78 16.18
EPS (TTM): -- -- --
ROI: -- 6.59 14.60
ROE: -- 10.42 13.87

BRIEF-Biotelemetry Q2 adjusted earnings per share $0.23

* Biotelemetry, inc. Reports second quarter 2017 financial results

Aug 08 2017

BRIEF-Biotelemetry enters credit agreement related to Lifewatch acquisition

* Biotelemetry Inc - on July 12 in connection with closing of acquisition of Lifewatch AG entered into a credit agreement - SEC filing

Jul 14 2017

BRIEF-Lifewatch: BioTelemetry confirms success rate of 96.67 pct​

* ‍WITH DEFINITIVE END RESULT NOW AVAILABLE, BIOTELEMETRY (NASDAQ: BEAT) ( OFFEROR) CONFIRMED TODAY SUCCESS RATE OF 96.67 PERCENT​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 04 2017

BRIEF-Lifewatch: BioTelemetry holds 96.5% of share capital of Lifewatch

* BIOTELEMETRY HOLDS 17,831,214 LIFEWATCH SHARES, CORRESPONDING TO 96.50% OF VOTING RIGHTS AND SHARE CAPITAL OF LIFEWATCH Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 29 2017

BRIEF-Lifewatch: 82 pct of shares of Lifewatch​ tendered

* EQS-ADHOC: LIFEWATCH AG: BIOTELEMETRY, INC. RELEASES PROVISIONAL INTERIM RESULT OF PUBLIC OFFER FOR LIFEWATCH AG​‍

Jun 09 2017

BRIEF-Lifewatch: Biotelemetry announces extension of main offer period for public offer

* LIFEWATCH AG: BIOTELEMETRY, INC. ANNOUNCES EXTENSION OF THE MAIN OFFER PERIOD FOR PUBLIC OFFER FOR LIFEWATCH AG

May 24 2017

BRIEF-LifeWatch and BioTelemetry announce receipt of antitrust clearance

* LIFEWATCH AG AND BIOTELEMETRY, INC. ANNOUNCE RECEIPT OF ANTITRUST CLEARANCE

May 08 2017

BRIEF-BioTelemetry announces receipt of antitrust clearance for its acquisition of LifeWatch AG

* Biotelemetry, inc. Announces receipt of antitrust clearance for its acquisition of lifewatch ag

May 08 2017

BRIEF-Biotelemetry Q1 adjusted earnings per share $0.16

* Biotelemetry Inc reports first quarter 2017 financial results

May 03 2017

BRIEF-Biotelemetry issues prospectus for public tender offer

* Biotelemetry, Inc. issues prospectus for public tender offer to acquire lifewatch ag

Apr 24 2017

Earnings vs. Estimates